Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies

Steven R. Levine, Robin L. Brey, Christine L.M. Joseph, Sue Havstad

Research output: Contribution to journalArticlepeer-review

99 Scopus citations

Abstract

Antiphospholipid antibodies are a marker for an increased risk of thrombosis, including stroke and transient ischemic attacks. Prior studies suggest that patients with these antibodies and thrombosis may be at increased risk for recurrent thrombotic events. We prospectively evaluated 75 patients with antiphospholipid antibodies and cerebral or ocular ischemia for recurrence of thrombosis. Twenty-six patients (35%) experienced a recurrent stroke or transient ischemic attack, with a mean time to recurrence of 1.18 years. Hypertension significantly increased the risk of a recurrent transient ischemic attack. Patients with coronary artery disease were three times as likely as those without to have a recurrent stroke or transient ischemic attack. There was a trend for treatment with a combination of aspirin and dipyndamole to reduce the risk of recurrent thrombotic events after adjusting for sex and ethnicity.

Original languageEnglish (US)
Pages (from-to)I-29-I-32
JournalStroke
Volume23
Issue number2
StatePublished - Feb 1992

Keywords

  • Anticoagulants, anticardiolipin antibodies
  • Cerebral ischemia

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Fingerprint Dive into the research topics of 'Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies'. Together they form a unique fingerprint.

Cite this